home / stock / mack / mack news


MACK News and Press, Merrimack Pharmaceuticals Inc. From 08/05/21

Stock Information

Company Name: Merrimack Pharmaceuticals Inc.
Stock Symbol: MACK
Market: NASDAQ
Website: merrimack.com

Menu

MACK MACK Quote MACK Short MACK News MACK Articles MACK Message Board
Get MACK Alerts

News, Short Squeeze, Breakout and More Instantly...

MACK - Merrimack Reports Second Quarter 2021 Financial Results

Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) (“Merrimack” or the “Company”) today announced its second quarter 2021 financial results for the period ended June 30, 2021. “We are pleased to report continued reductions in our operating expenses as w...

MACK - InvestorNewsBreaks - 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Strategic Board Appointments

180 Life Sciences (NASDAQ: ATNF) , a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it has appointed Russell T. Ray, MBA and Teresa DeLuca MD, MBA to its board of direc...

MACK - 180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors

MENLO PARK, Calif., May 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today anno...

MACK - Merrimack Reports Full Year 2020 Financial Results

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full year 2020 financial results for the period ended December 31, 2020. “We are pleased that both Ipsen Pharmaceuticals and Elevation Oncology contin...

MACK - NVAX, APPN, CNDT and MACK among after-hours movers

Gainers: [[CASA]] +25.2%. [[TA]] +8.2%. [[NVAX]] +6.9%. [[AXTI]] +5.5%. [[MACK]] +5%.Losers: [[RXT]] -11.8%. [[CNDT]] -8.3%. [[EHTH]] -6.3%. [[APPN]] -5.4%. [[CENX]] -4%. For further details see: NVAX, APPN, CNDT and MACK among after-hours movers

MACK - TWLO, RIGL, ONTX and MACK among premarket gainers

Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS) +35%.Cleveland BioLabs (CB...

MACK - Wall Street Breakfast: What Moved Markets

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. All three major stock market indexes closed at all-time highs Friday as D.C. lawmakers appeared to make progress toward passing a COVID stimu...

MACK - Sutro Biopharma, Merrimack Pharmaceuticals leads healthcare gainers; Precision BioSciences, Cortexyme among major losers

Gainers: Sutro Biopharma (STRO) +33%, Merrimack Pharmaceuticals (MACK) +18%, Evogene (EVGN) +18%, BioCryst Pharmaceuticals (BCRX) +16%, PDS Biotechnology (PDSB) +15%.Losers: Precision BioSciences DTIL -21%, Cortexyme CRTX -17%, Chembio Di...

MACK - Enlivex Therapeutics, Cellectar Biosciences leads healthcare gainers; ReWalk Robotics, Precision BioSciences among major losers

Gainers: Enlivex Therapeutics (ENLV) +24%, Cellectar Biosciences (CLRB) +18%, Omeros (OMER) +15%, Trxade Group (MEDS) +13%, AlloVir (ALVR) +10%.Losers: ReWalk Robotics (RWLK) -11%, Precision BioSciences (DTIL) -11%, Merrimack Pharmaceutic...

MACK - Development of Advanced Novel AML Drugs Target Increasing Cases of Acute Myeloid Leukemia

Palm Beach, FL – December 3, 2020 – Acute myeloid leukemia (AML) is a rare and heterogeneous blood cancer with a poor overall prognosis. It affects predominantly older adults with a median age at diagnosis of 66 years but also includes about 15% of children from birth to 19 ye...

Previous 10 Next 10